Implementation of a fully remote randomized clinical trial with cardiac monitoring

Keyphrases

• Randomized Clinical Trial 100%
• Hydroxychloroquine 100%
• Cardiac Monitoring 100%
• Safety Monitoring 66%
• Nasal Swab 66%
• Azithromycin 66%
• COVID-19 33%
• COVID-19 Pandemic 33%
• Oxygen Saturation 33%
• Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) 33%
• Infection Risk 33%
• Clinical Trials 33%
• Placebo Groups 33%
• Vital Signs 33%
• Respiratory Rate 33%
• Heart Rate 33%
• Adverse Events 33%
• Self-collected 33%
• Rate Saturation 33%
• Adherence Rate 33%
• QTc Interval 33%
• Cardiovascular Safety 33%
• Digital Health Technology 33%
• SARS-CoV-2 Testing 33%
• Consumer Devices 33%
• Internet-enabled 33%
• Sex Assigned at Birth 33%
• Innovative Approaches 33%
• Core Laboratory 33%
• QTc Prolongation 33%
• AliveCor 33%
• KardiaMobile 33%
• Remote Clinical Trials 33%
• Six-lead ECG 33%

Medicine and Dentistry

• Hydroxychloroquine 100%
• Randomized Clinical Trials 100%
• COVID-19 66%
• Clinical Trial 66%
• Nose Smear 66%
• Azithromycin 66%
• Placebo 33%
• SARS Coronavirus 33%
• Oxygen Saturation 33%
• Vital Sign 33%
• Severe Acute Respiratory Syndrome Coronavirus 2 33%
• Electrocardiogram 33%
• Health Technology 33%
• ECG Leads 33%
• QTc Interval 33%
• Digital Health 33%
• Electrocardiography 33%
• Cardiovascular System 33%
• Diseases 33%
• Adverse Event 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Randomized Clinical Trial 100%
• Hydroxychloroquine 100%
• Diseases 100%
• SARS Coronavirus 66%
• Coronavirinae 66%
• Clinical Trial 66%
• Azithromycin 66%
• Adverse Event 33%
• Placebo 33%